checkAd
    Startseite > Aktien > Purple Biotech > Nachrichten
    Purple Biotech Aktie
    0,4900
     
    EUR
    +2,08 %
    +0,0100 EUR
    Letzter Kurs 13.05.24 Tradegate
    0,4740
     
    EUR
    6.400 STK
    Geldkurs 16:18:23
    0,5050
     
    EUR
    6.000 STK
    Briefkurs 16:18:23
    ISIN: US74638P1093 · WKN: A2QLTP · SYM: 1YI1 · Israel

    Neueste Nachrichten

    Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
    25.04.24 · globenewswire · Purple Biotech
    Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
    28.03.24 · globenewswire · Purple Biotech
    Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
    14.03.24 · globenewswire · Purple Biotech
    Purple Biotech Reports Fourth Quarter and Full-Year 2023 Financial Results
    05.03.24 · globenewswire · Purple Biotech
    Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
    27.02.24 · globenewswire · Purple Biotech
    Purple Biotech Convenes a Head & Neck Cancer Scientific Advisory Board in Preparation for NT219 Phase 2 Trial
    13.02.24 · globenewswire · Purple Biotech
    Purple Biotech Reaches Recommended Phase 2 Dose for NT219
    01.02.24 · globenewswire · Purple Biotech
    Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
    20.12.23 · globenewswire · Purple Biotech
    Purple Biotech Reports Third Quarter 2023 Financial Results
    21.11.23 · globenewswire · Purple Biotech
    Purple Biotech Fortifies NT219 Patent Protection
    02.11.23 · globenewswire · Purple Biotech
    Purple Biotech Announces Closing of $5 Million Registered Direct Offering
    19.10.23 · globenewswire · Purple Biotech
    Purple Biotech Announces $5 Million Registered Direct Offering
    17.10.23 · globenewswire · Purple Biotech